Optometry Education and CME

Select a Specialty

Ophthalmology
COPECME

Ocular Surface Diseases, Disorders, and Dysfunctions®, Volume 4, Number 2

This activity is supported by an educational grant from Shire.

Expiration Date: 11/1/2019
Credit Type(s): CME / COPE | Credit: 1.25

Ocular surface disease (OSD) is a group of disorders commonly seen in ophthalmic practice, but it is challenging to differentially diagnose and is frequently…

go to activity»
J555-HEA001
CME

Cataract and Refractive 360—Fundamentals, Techniques, & Technology; Volume 3, Number 2

This activity is supported by educational grants from Alcon Laboratories, Inc.; Bausch + Lomb; Carl Zeiss Meditec, Inc.; and J & J Vision.

Expiration Date: 9/25/2019
Credit Type(s): CME | Credit: 1.25

Successful cataract surgery involves a multifactorial process that relies on numerous interconnected assessment, planning, and execution procedures. Phacodynamics, which…

go to activity»
21st Century Perspective on glaucoma care activity listing image optometry

Melton, Thomas, and Vollmer’s 21st Century Perspective on Glaucoma Patient Care

This activity is supported by an unrestricted grant from Bausch + Lomb.

July 25, 2018

In this activity, the authors cover all the salient features of glaucoma patient care, including diagnosis, medical therapy and numerous clinical pearls….

go to activity»
Reducing IOP and Improving Compliance in 2018: New Opportunities in Medical Glaucoma Treatment
CME

Reducing IOP and Improving Compliance in 2018: New Opportunities in Medical Glaucoma Treatment

This activity is supported by an educational grant from Aerie Pharmaceuticals, Inc.

Expiration Date: 5/25/2019
Credit Type(s): CME | Credit: 1.25

Glaucoma is the leading cause of irreversible blindness worldwide, with an estimated 70 million people currently affected by the condition. Advances in imaging have…

go to activity»
Ocular Surface
CME

Preserving the Ocular Surface: Practice Pearls Part 3

This activity is supported by educational grants from Allergan, Inc.; Bausch + Lomb; and Shire.

Expiration Date: 4/23/2019
Credit Type(s): CME | Credit: 0.5

Dry eye symptoms are experienced by many patients, especially with aging. Unfortunately, millions of patients with ocular surface disease are underdiagnosed in the…

go to activity»
J970
CME

Assessing and Treating Diabetic Retinopathy Amid New Recommendations and Evidence

This activity is supported by an educational grant from Genentech, Inc.

Expiration Date: 4/9/2019
Credit Type(s): CME | Credit: 0.75

Although rapid advances have been made in the treatment of diabetic macular edema (DME), particularly with the use of intravitreal therapy, options for the management of…

go to activity»
J148
COPE

System-based Screening and Referral for Diabetic Retinopathy

This activity is supported by an educational grant from Genentech, Inc.

Expiration Date: 10/1/2019
Credit Type(s): COPE | Credit: 1

Diabetic retinopathy (DR) continues to be a leading cause of blindness in the developed world. Early diagnosis and prompt treatment utilizing laser and/or intravitreal…

go to activity»
J504
CME

Rapid Response from DC: Management of Miosis and Postsurgical Pain in Cataract Surgery

This activity is supported by an educational grant from Omeros Corporation.

Expiration Date: 9/3/2019
Credit Type(s): CME | Credit: 0.75

Interoperative miosis increases the risk of complications such as posterior capsule rupture, vitreous loss, corneal edema, and cystoid macular edema during cataract…

go to activity»
DR
CME

Assessing and Treating Diabetic Retinopathy Amid New Recommendations and Evidence

This activity is supported by an educational grant from Genentech, Inc.

Expiration Date: 6/10/2019
Credit Type(s): CME | Credit: 1.25

Although rapid advances have been made in the treatment of diabetic macular edema (DME), particularly with the use of intravitreal therapy, options for the management of…

go to activity»
Proliferative and Non-proliferative Diabetic Retinopathy: Weighing the Evidence for Medical Treatment
CME

Proliferative and Nonproliferative Diabetic Retinopathy: Weighing the Evidence for Medical Treatment

This activity is supported by an educational grant from Genentech, Inc.

Expiration Date: 4/26/2019
Credit Type(s): CME | Credit: 0.5

Although rapid advances have been made in the treatment of diabetic macular edema (DME), particularly with the use of intravitreal therapy, options for the management of…

go to activity»
Macular Degeneration CME
CME

Advancing Science on Age-related Macular Degeneration

This activity is supported by an educational grant from Genentech, Inc.

Expiration Date: 3/25/2019
Credit Type(s): CME | Credit: 1.25

Age-related macular degeneration (AMD) is one of the leading causes of adult blindness and visual impairment. Because age is a major risk factor for developing AMD, it…

go to activity»
J894
CME

Improving the Clinical Picture of IOP in Glaucoma Through Innovative Treatments

This activity is supported by an educational grant from Bausch + Lomb.

Expiration Date: 4/8/2019
Credit Type(s): CME | Credit: 0.75

Glaucoma is the leading cause of irreversible blindness worldwide, with an estimated 70 million people currently affected by the condition. Advances in imaging have…

go to activity»